Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism

被引:372
作者
Kudo, O
Sabokbar, A
Pocock, A
Itonaga, I
Fujikawa, Y
Athanasou, NA
机构
[1] Univ Oxford, Nuffield Dept Orthopaed Surg, Dept Pathol, Oxford OX3 7LD, England
[2] Oita Med Univ, Dept Orthopaed Surg, Oita 8795593, Japan
基金
英国惠康基金;
关键词
osteoclast; interleukin-6 (IL-6); interleukin-11 (IL-11); glycoprotein 130 (gp-130); bone resorption;
D O I
10.1016/S8756-3282(02)00915-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Interleukin-6 (IL-6) and interleukin-11 (IL-11) are known to influence osteoclast formation and bone resorption. In order to determine whether IL-6 and IL-11 could independently support human osteoclast formation, these factors were added to cultures of human peripheral blood mononuclear cells of the monocyte (CD14(+)) fraction in the presence of macrophage colony-stimulating factor (M-CSF). Under these conditions, IL-6 and IL-11 induced the formation of multinucleated cells which were positive for TRAP, VNR, and calcitonin receptor and capable of lacunar resorption. Osteoclastogenesis induced by IL-6 and IL-11 was inhibited by the addition of an anti-gp130 antibody but not by osteoprotegerin. These results indicate that IL-6 and IL-11, which are thought to play a role in several osteolytic bone disorders, are directly capable of inducing osteoclast formation by a RANKL-independent mechanism. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 37 条
[1]  
ALHUMIDAN A, 1991, J BONE MINER RES, V6, P3
[2]   IMMUNOPHENOTYPIC DIFFERENCES BETWEEN OSTEOCLASTS AND MACROPHAGE POLYKARYONS - IMMUNOHISTOLOGICAL DISTINCTION AND IMPLICATIONS FOR OSTEOCLAST ONTOGENY AND FUNCTION [J].
ATHANASOU, NA ;
QUINN, J .
JOURNAL OF CLINICAL PATHOLOGY, 1990, 43 (12) :997-1003
[3]   Coordinated cytokine expression by stromal and hematopoietic cells during human osteoclast formation [J].
Atkins, GJ ;
Haynes, DR ;
Geary, SM ;
Loric, M ;
Crotti, TN ;
Findlay, DM .
BONE, 2000, 26 (06) :653-661
[4]   Tumor necrosis factor-α induces differentiation of and bone resorption by osteoclasts [J].
Azuma, Y ;
Kaji, K ;
Katogi, R ;
Takeshita, S ;
Kudo, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (07) :4858-4864
[5]   IL-6: Insights into novel biological activities [J].
Barton, BE .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1997, 85 (01) :16-20
[6]   MECHANISMS OF BONE-LESIONS IN MULTIPLE-MYELOMA [J].
BATAILLE, R ;
CHAPPARD, D ;
KLEIN, B .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1992, 6 (02) :285-295
[7]  
CHIBA J, 1994, CLIN ORTHOP RELAT R, V300, P304
[8]   Interleukin-6: A potential mediator of the massive osteolysis in patients with Gorham-Stout disease [J].
Devlin, RD ;
Bone, HG ;
Roodman, GD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (05) :1893-1897
[9]   IL-6 mediates the effects of IL-1 or TNF, but not PTHrP or 1,25(OH)2D3, on osteoclast-like cell formation in normal human bone marrow cultures [J].
Devlin, RD ;
Reddy, SV ;
Savino, R ;
Ciliberto, G ;
Roodman, GD .
JOURNAL OF BONE AND MINERAL RESEARCH, 1998, 13 (03) :393-399
[10]   The human osteoclast precursor circulates in the monocyte fraction [J].
Fujikawa, Y ;
Quinn, JMW ;
Sabokbar, A ;
McGee, JO ;
Athanasou, NA .
ENDOCRINOLOGY, 1996, 137 (09) :4058-4060